In vitro study demonstrates fungal melanins protect neuroblastoma cells against oxidative stress, suggesting potential therapeutic utility in Parkinson's disease.
Oxidative stress is strongly associated with neuronal damage in neurodegenerative diseases, such as Parkinson’s disease (PD). Fungal melanins are remarkable free radical scavengers; however, their capacity to protect neurons from reactive oxygen species (ROS)-induced damage remains understudied. This research evaluated the neuroprotective effects of fungal melanins and their arginine-modified counterparts on SH-SY5Y cells against neurotoxins, as well as their impact on ROS levels. Exposure to 0.6 mM H2O2 or 1 mM MPP+ markedly elevated ROS levels and reduced cell viability to approximately 56% and 60%, respectively. At 10 μg/mL, melanins from Apioperdon pyriforme, Russula nigricans, and Xylaria nigripes significantly protected cells against H2O2 cytotoxicity, whereas arginine-modified melanin from the skin of Scleroderma sinnamariense significantly attenuated MPP+ cytotoxicity. Further dose-dependent evaluation revealed that melanin from A. pyriforme (10–12 μg/mL) displayed activity comparable to the positive control (164 μg/mL N-Acetylcysteine (NAC)) against H2O2 by increasing cell viability up to 90%. Similarly, arginine-modified melanin from S. sinnamariense (6–10 μg/mL) and NAC showed a comparable protective effect against MPP+, boosting cell viability up to 80%. Both samples suppressed ROS to levels comparable to, or lower than, the untreated control. Melanin from A. pyriforme is a promising candidate for further research into complementary therapies for PD.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: